To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability

NCT05856058 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Graft-versus-host Disease

Interventions

DRUG: SHR0302

Sponsor

Jiangsu HengRui Medicine Co., Ltd.